166 related articles for article (PubMed ID: 34390296)
1. Next-generation balloon-expandable Myval transcatheter heart valve in low-risk aortic stenosis patients.
García-Gómez M; Delgado-Arana JR; Halim J; De Marco F; Trani C; Martin P; Won-Keun K; Montorfano M; den Heijer P; Bedogni F; Sardella G; IJsselmuiden AJJ; Campante Teles R; Aristizabal-Duque CH; Gordillo X; Santos-Martinez S; Barrero A; Gómez-Salvador I; Ancona M; Redondo A; Román JAS; Amat-Santos IJ
Catheter Cardiovasc Interv; 2022 Feb; 99(3):889-895. PubMed ID: 34390296
[TBL] [Abstract][Full Text] [Related]
2. First-in-human evaluation of a novel balloon-expandable transcatheter heart valve in patients with severe symptomatic native aortic stenosis: the MyVal-1 study.
Sharma SK; Rao RS; Chandra P; Goel PK; Bharadwaj P; Joseph G; Jose J; Mahajan AU; Mehrotra S; Sengottovelu G; Ajit Kumar VK; Manjunath CN; Abhaichand RK; Sethi R; Seth A;
EuroIntervention; 2020 Aug; 16(5):421-429. PubMed ID: 31566572
[TBL] [Abstract][Full Text] [Related]
3. Early clinical and haemodynamic matched comparison of balloon-expandable valves.
Delgado-Arana JR; Gordillo-Monge MX; Halim J; De Marco F; Trani C; Martin P; Infusino F; Ancona M; den Heijer P; Bedogni F; Nombela Franco L; Moreno R; Sargella G; Montorfano M; Aristizabal-Duque C; Romero-Delgado T; Santos S; Barrero A; Gomez Salvador I; IJsselmuiden S; Redondo Diéguez A; San Román Calvar JA; Amat-Santos IJ
Heart; 2022 May; 108(9):725-732. PubMed ID: 34285104
[TBL] [Abstract][Full Text] [Related]
4. Latest-iteration balloon- and self-expandable transcatheter valves for severe bicuspid aortic stenosis: the TRITON study.
Amat-Santos IJ; García-Gómez M; de Marco F; Won-Keun K; Brito J; Halim J; Jose J; Sengotuvelu G; Seth A; Terkelsen C; Protasiewicz M; Bonilla N; García B; Sánchez-Luna JP; Blasco-Turrión S; González JC; González-Bartol E; Ijsselmuiden AJJ; Gómez-Salvador I; Carrasco Moraleja M; San Román A
Rev Esp Cardiol (Engl Ed); 2023 Nov; 76(11):872-880. PubMed ID: 36898524
[TBL] [Abstract][Full Text] [Related]
5. Comparing two-year outcomes of balloon-expandable Myval and self-expanding Evolut R in severe aortic valve stenosis.
Moscarella E; Ielasi A; Montonati C; Pellegrini D; Pellicano M; Briguglia D; D'Alessandro V; Giannini F; Gamardella M; Medda M; Guagliumi G; Banfi C; Glauber M; Tespili M
Int J Cardiol; 2024 Apr; 400():131701. PubMed ID: 38168557
[TBL] [Abstract][Full Text] [Related]
6. LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.
Baumbach A; van Royen N; Amat-Santos IJ; Hudec M; Bunc M; Ijsselmuiden A; Laanmets P; Unic D; Merkely B; Hermanides RS; Ninios V; Protasiewicz M; Rensing BJWM; Martin PL; Feres F; De Sousa Almeida M; van Belle E; Linke A; Ielasi A; Montorfano M; Webster M; Toutouzas K; Teiger E; Bedogni F; Voskuil M; Pan M; Angerås O; Kim WK; Rothe J; Kristić I; Peral V; Garg S; Elzomor H; Tobe A; Morice MC; Onuma Y; Soliman O; Serruys PW;
Lancet; 2024 Jun; 403(10445):2695-2708. PubMed ID: 38795719
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Angiographic Assessment of Aortic Regurgitation after Transcatheter Aortic Valve Implantation among Three Balloon-Expandable Valves.
Kawashima H; Wang R; Mylotte D; Jagielak D; De Marco F; Ielasi A; Onuma Y; den Heijer P; Terkelsen CJ; Wijns W; Serruys PW; Soliman O
Glob Heart; 2021 Mar; 16(1):20. PubMed ID: 33833944
[TBL] [Abstract][Full Text] [Related]
8. Safety and effectiveness of the novel Myval Octacor transcatheter heart valve in severe, symptomatic aortic valve stenosis - A real-world Indian experience (The OCTACOR India Study).
Jose J; Mandalay A; Cholenahally MN; Khandenahally RS; Budnur SC; Parekh M; Rao RS; Seth A; Chandra P; Kapoor R; Agarwal P; Mathur A; Kumar V; Kanchanahalli SS; Mullasari AS; Subban V; Khanolkar UB; Mehrotra S; Chopra M; Jain RK; Mehta H; Gupta R; Kumar V; Raghuraman B; Shastri N; Elzomor H; Soliman O; Gunasekaran S
Cardiovasc Revasc Med; 2024 Jun; 63():1-7. PubMed ID: 38423848
[TBL] [Abstract][Full Text] [Related]
9. Safety and performance parameters of the Myval transcatheter aortic valve bioprosthesis: The SAPPHIRE prospective registry.
Testa L; Criscione E; Popolo Rubbio A; Squillace M; Ielasi A; Tespili M; Brambilla N; Bedogni F
Cardiovasc Revasc Med; 2023 Oct; 55():22-27. PubMed ID: 37076413
[TBL] [Abstract][Full Text] [Related]
10. Bioprosthetic Valve Performance After Transcatheter Aortic Valve Replacement With Self-Expanding Versus Balloon-Expandable Valves in Large Versus Small Aortic Valve Annuli: Insights From the CHOICE Trial and the CHOICE-Extend Registry.
Abdelghani M; Mankerious N; Allali A; Landt M; Kaur J; Sulimov DS; Merten C; Sachse S; Mehilli J; Neumann FJ; Frerker C; Kurz T; El-Mawardy M; Richardt G; Abdel-Wahab M
JACC Cardiovasc Interv; 2018 Dec; 11(24):2507-2518. PubMed ID: 30503595
[TBL] [Abstract][Full Text] [Related]
11. Single center experience with the balloon-expandable Myval transcatheter aortic valve system with the first 100 patients: 30-day and 1-year follow-up.
Magyari B; Kittka B; Goják I; Kasza G; Schönfeld K; Szapáry LB; Simon M; Kiss R; Bertalan A; Várady E; Gyimesi A; Szokodi I; Horváth I
Catheter Cardiovasc Interv; 2023 Dec; 102(7):1317-1330. PubMed ID: 37870123
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter aortic valve replacement in bicuspid aortic valve disease.
Mylotte D; Lefevre T; Søndergaard L; Watanabe Y; Modine T; Dvir D; Bosmans J; Tchetche D; Kornowski R; Sinning JM; Thériault-Lauzier P; O'Sullivan CJ; Barbanti M; Debry N; Buithieu J; Codner P; Dorfmeister M; Martucci G; Nickenig G; Wenaweser P; Tamburino C; Grube E; Webb JG; Windecker S; Lange R; Piazza N
J Am Coll Cardiol; 2014 Dec; 64(22):2330-9. PubMed ID: 25465419
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of a randomized clinical trial comparing safety and efficacy of myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: The LANDMARK trial.
Kawashima H; Soliman O; Wang R; Ono M; Hara H; Gao C; Zeller E; Thakkar A; Tamburino C; Bedogni F; Neumann FJ; Thiele H; Abdel-Wahab M; Morice MC; Webster M; Rosseel L; Mylotte D; Onuma Y; Wijns W; Baumbach A; Serruys PW
Am Heart J; 2021 Feb; 232():23-38. PubMed ID: 33160946
[TBL] [Abstract][Full Text] [Related]
14. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.
Husser O; Pellegrini C; Kessler T; Burgdorf C; Thaller H; Mayr NP; Ott I; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C
JACC Cardiovasc Interv; 2015 Dec; 8(14):1809-16. PubMed ID: 26718512
[TBL] [Abstract][Full Text] [Related]
15. The Allegra transcatheter heart valve: Short term results from a multicenter registry.
Wolfrum M; Moccetti F; Piuhola J; Lehtola H; Baz JA; Iñiguez A; van Nunen LX; Tonino PAL; Niemelä M; Toggweiler S
Catheter Cardiovasc Interv; 2021 Nov; 98(6):1204-1209. PubMed ID: 34137483
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation.
Sanchez-Luna JP; Martín P; Dager AE; Charry PD; Beltrán JR; Sánchez-Recalde Á; Giannini F; Gómez-Menchero A; Pan M; Ielasi A; Monastyrski A; Barbanti M; Fernandez-Avilés F; Ancona MB; Mussayev A; De Brahi JP; Lamelas P; Sánchez-Pérez A; García Puerta M; Ortiz M; Gonzalez-Gutiérrez JC; Marengo G; Gómez J; Gonzalez-Bartol E; Stepanenko A; Gomez-Salvador I; San Román JA; Amat-Santos IJ
EuroIntervention; 2023 Sep; 19(7):580-588. PubMed ID: 37565470
[TBL] [Abstract][Full Text] [Related]
17. 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial.
Abdel-Wahab M; Landt M; Neumann FJ; Massberg S; Frerker C; Kurz T; Kaur J; Toelg R; Sachse S; Jochheim D; Schäfer U; El-Mawardy M; Robinson DR; Richardt G;
JACC Cardiovasc Interv; 2020 May; 13(9):1071-1082. PubMed ID: 32305398
[TBL] [Abstract][Full Text] [Related]
18. Operator preference and determinants of size selection when additional intermediate-size aortic transcatheter heart valves are made available.
Kawashima H; Serruys PW; Mylotte D; Rosseel L; Amat-Santos IJ; Rao RS; Onuma Y; Wijns W; Abdel-Wahab M; Baumbach A; Soliman O
Int J Cardiol; 2021 Sep; 338():168-173. PubMed ID: 34147554
[TBL] [Abstract][Full Text] [Related]
19. Myval transcatheter heart valve system in the treatment of severe symptomatic aortic stenosis.
Sharma SK; Rao RS; Chopra M; Sonawane A; Jose J; Sengottuvelu G
Future Cardiol; 2021 Jan; 17(1):73-80. PubMed ID: 32628046
[TBL] [Abstract][Full Text] [Related]
20. A Direct Comparison of Self-Expandable Portico Versus Balloon-Expandable Sapien 3 Devices for Transcatheter Aortic Valve Replacement: A Case-Matched Cohort Study.
Mas-Peiro S; Seppelt PC; Weiler H; Mohr GL; Papadopoulos N; Walther T; Zeiher AM; Fichtlscherer S; Vasa-Nicotera M
J Invasive Cardiol; 2019 Jul; 31(7):E199-E204. PubMed ID: 31257214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
